{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:05:27Z","timestamp":1784077527652,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53254-4","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:55:02Z","timestamp":1778882102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesoporous silica nanoparticles functionalized with folic acid and zinc for enhanced targeted delivery of daunorubicin to breast cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Seyedeh Elaheh","family":"Sheykholeslami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim Kaveh","family":"Farsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeganeh","family":"Azari Incheh Sablagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Afshari-BehbahaniZadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhosein","family":"Keshvadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Noorbazargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"53254_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124697","volume":"242","author":"F Hosseini","year":"2023","unstructured":"Hosseini, F. et al. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin\/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation. Int. J. Biol. Macromol. 242, 124697. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124697 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"53254_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111648","volume":"144","author":"K Ganesan","year":"2020","unstructured":"Ganesan, K. & Xu, B. Deep frying cooking oils promote the high risk of metastases in the breast-a critical review. Food Chem. Toxicol. 144, 111648. https:\/\/doi.org\/10.1016\/j.fct.2020.111648 (2020).","journal-title":"Food Chem. Toxicol."},{"key":"53254_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/s17071572","volume":"17","author":"L Wang","year":"2017","unstructured":"Wang, L. Early diagnosis of breast cancer. Sensors 17, 1572. https:\/\/doi.org\/10.3390\/s17071572 (2017).","journal-title":"Sensors"},{"key":"53254_CR4","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2018.05.01","volume":"7","author":"M Hattori","year":"2018","unstructured":"Hattori, M. & Iwata, H. Advances in treatment and care in metastatic breast cancer (MBC): Are there MBC patients who are curable. Chin. Clin. Oncol. 7, 23. https:\/\/doi.org\/10.21037\/cco.2018.05.01 (2018).","journal-title":"Chin. Clin. Oncol."},{"key":"53254_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126808","volume":"253","author":"M Zaer","year":"2023","unstructured":"Zaer, M. et al. Doxorubicin-loaded niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach. Int. J. Biol. Macromol. 253, 126808. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126808 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"53254_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-443-15518-5.00013-6","volume-title":"Functionalized Nanomaterials for Cancer Research","author":"DM Rad","year":"2024","unstructured":"Rad, D. M. et al. Functionalized Nanomaterials for Cancer Research 37\u201362 (Elsevier, 2024)."},{"key":"53254_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.micromeso.2023.112810","volume":"363","author":"C Carucci","year":"2024","unstructured":"Carucci, C. et al. \u03b2-N-acetylglucosaminidase grafted on mesoporous silica nanoparticles. A bionanoantibiotic system against Staphylococcus aureus bacteria. Microporous Mesoporous Mater. 363, 112810. https:\/\/doi.org\/10.1016\/j.micromeso.2023.112810 (2024).","journal-title":"Microporous Mesoporous Mater."},{"key":"53254_CR8","doi-asserted-by":"publisher","DOI":"10.7497\/j.issn.2095-3941.2014.01.003","volume":"184","author":"SS Park","year":"2019","unstructured":"Park, S. S. et al. Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery. Mater. Des. 184, 108187. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2014.01.003 (2019).","journal-title":"Mater. Des."},{"key":"53254_CR9","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1021\/acsomega.7b00978","volume":"2","author":"C Murugan","year":"2017","unstructured":"Murugan, C., Venkatesan, S. & Kannan, S. Cancer therapeutic proficiency of dual-targeted mesoporous silica nanocomposite endorses combination drug delivery. ACS Omega 2, 7959\u20137975. https:\/\/doi.org\/10.1021\/acsomega.7b00978 (2017).","journal-title":"ACS Omega"},{"key":"53254_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202408898","author":"S Yousefiasl","year":"2025","unstructured":"Yousefiasl, S. et al. Smart mesoporous silica nanoparticles in cancer: Diagnosis, treatment, immunogenicity, and clinical translation. Small https:\/\/doi.org\/10.1002\/smll.202408898 (2025).","journal-title":"Small"},{"key":"53254_CR11","doi-asserted-by":"publisher","DOI":"10.1039\/d4me00098f","author":"K Girigoswami","year":"2024","unstructured":"Girigoswami, K., Pallavi, P. & Girigoswami, A. Crafting porous nanoscaled architecture as a potential frontier for drug delivery. Mol. Syst. Des. Eng. https:\/\/doi.org\/10.1039\/d4me00098f (2024).","journal-title":"Mol. Syst. Des. Eng."},{"key":"53254_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106038","volume":"100","author":"FN Kaci","year":"2024","unstructured":"Kaci, F. N. & Daglioglu, C. 3-Aminobenzamide-linked multifunctional nanoparticles enhances anticancer activity of low-dose cisplatin chemotherapy in lung adenocarcinoma. J. Drug Deliv. Sci. Technol. 100, 106038 (2024).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"53254_CR13","doi-asserted-by":"crossref","unstructured":"Kaci, F. N. & Daglioglu, C. 3-aminobenzamide-linked multifunctional nanoparticles: A potent strategy for modulating PARP1 in cervical cancer cells. Cell Biochem. Biophys. 1\u20138 (2025).","DOI":"10.1007\/s12013-025-01813-3"},{"key":"53254_CR14","doi-asserted-by":"publisher","first-page":"45417","DOI":"10.1021\/acsomega.5c05302","volume":"10","author":"S Sarnaik","year":"2025","unstructured":"Sarnaik, S. et al. Folic acid-chitosan conjugated mesoporous silica nanoparticles for enhanced Piceatannol uptake in MCF-7 breast cancer cells. ACS Omega 10, 45417\u201345437 (2025).","journal-title":"ACS Omega"},{"key":"53254_CR15","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1039\/D5RA10048H","volume":"16","author":"E Serag","year":"2026","unstructured":"Serag, E., El-Fakharany, E. M., El-Maradny, Y. A. & El-Khouly, M. E. Folic acid-functionalized mesoporous silica nanoparticles integrating fluorouracil-derived carbon dots and porphyrin for targeted breast cancer chemo-photodynamic therapy. RSC Adv. 16, 8300\u20138321 (2026).","journal-title":"RSC Adv."},{"key":"53254_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124314","author":"A Nair","year":"2024","unstructured":"Nair, A. et al. Polymeric functionalization of mesoporous silica nanoparticles: Biomedical insights. Int. J. Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124314 (2024).","journal-title":"Int. J. Pharm."},{"key":"53254_CR17","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1515\/nanoph-2021-0207","volume":"10","author":"M Deinavizadeh","year":"2021","unstructured":"Deinavizadeh, M. et al. Smart NIR-light and pH responsive doxorubicin-loaded GNRs@ SBA-15-SH nanocomposite for chemo-photothermal therapy of cancer. Nanophotonics 10, 3303\u20133319 (2021).","journal-title":"Nanophotonics"},{"key":"53254_CR18","doi-asserted-by":"publisher","first-page":"18754","DOI":"10.1021\/acs.jpcc.2c05254","volume":"126","author":"M Deinavizadeh","year":"2022","unstructured":"Deinavizadeh, M. et al. NIR\/pH dual-responsive DOX-loaded AuNRs@ S-\u03b2-CD nanocomposite for highly effective chemo-photothermal synergistic therapy against lung cancer cells. J. Phys. Chem. C 126, 18754\u201318766 (2022).","journal-title":"J. Phys. Chem. C"},{"key":"53254_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54778-3","volume":"14","author":"M Deinavizadeh","year":"2024","unstructured":"Deinavizadeh, M. et al. Synergistic chemo-photothermal therapy using gold nanorods supported on thiol-functionalized mesoporous silica for lung cancer treatment. Sci. Rep. 14, 4373 (2024).","journal-title":"Sci. Rep."},{"key":"53254_CR20","doi-asserted-by":"publisher","first-page":"16332","DOI":"10.1021\/acsanm.3c02464","volume":"6","author":"M Deinavizadeh","year":"2023","unstructured":"Deinavizadeh, M. et al. Near-infrared\/pH dual-responsive nanosponges encapsulating gold nanorods for synergistic chemo-phototherapy of lung cancer. ACS Appl. Nano Mater. 6, 16332\u201316342 (2023).","journal-title":"ACS Appl. Nano Mater."},{"key":"53254_CR21","doi-asserted-by":"crossref","unstructured":"Ramhormozi, G. M. et al. Synergistic chemo-photothermal therapy using doxorubicin-loaded gold nanorods for enhanced apoptosis in lung cancer cells. Sci. Rep. (2025).","DOI":"10.21203\/rs.3.rs-7437340\/v1"},{"key":"53254_CR22","doi-asserted-by":"crossref","unstructured":"Lotfi, K., Zackrisson, A.-L. & Peterson, C. J. C. l. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance. 178, 141\u2013149 (2002).","DOI":"10.1016\/S0304-3835(01)00824-2"},{"key":"53254_CR23","first-page":"170","volume":"92","author":"H Lu","year":"2009","unstructured":"Lu, H., Yuan, G., He, Q. & Chen, H. Rapid analysis of anthracycline antibiotics doxorubicin and daunorubicin by microchip capillary electrophoresis. J. M. J. 92, 170\u2013173 (2009).","journal-title":"J. M. J."},{"key":"53254_CR24","doi-asserted-by":"crossref","unstructured":"Pourmadadi, M. et al. Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy. 115547 (2023).","DOI":"10.1016\/j.ejmech.2023.115547"},{"key":"53254_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtadv.2020.100066","volume":"6","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Biodegradable zinc-containing mesoporous silica nanoparticles for cancer therapy. Mater. Today Adv. 6, 100066. https:\/\/doi.org\/10.1016\/j.mtadv.2020.100066 (2020).","journal-title":"Mater. Today Adv."},{"key":"53254_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10238-020-00677-6","volume":"21","author":"C Hoppe","year":"2021","unstructured":"Hoppe, C., Kutschan, S., D\u00f6rfler, J., B\u00fcntzel, J. & Huebner, J. Zinc as a complementary treatment for cancer patients: A systematic review. Clin. Exp. Med. 21, 297\u2013313. https:\/\/doi.org\/10.1007\/s10238-020-00677-6 (2021).","journal-title":"Clin. Exp. Med."},{"key":"53254_CR27","doi-asserted-by":"publisher","first-page":"12858","DOI":"10.1039\/C9NR01277J","volume":"11","author":"P Ruenraroengsak","year":"2019","unstructured":"Ruenraroengsak, P. et al. Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells. Nanoscale 11, 12858\u201312870. https:\/\/doi.org\/10.1039\/C9NR01277J (2019).","journal-title":"Nanoscale"},{"key":"53254_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.colsurfb.2019.05.078","volume":"181","author":"Y Kuang","year":"2019","unstructured":"Kuang, Y. et al. Poly (amino acid)\/ZnO\/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy. Colloids Surf. B. Biointerfaces 181, 461\u2013469. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.05.078 (2019).","journal-title":"Colloids Surf. B. Biointerfaces"},{"key":"53254_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","volume":"141","author":"P Decuzzi","year":"2010","unstructured":"Decuzzi, P. et al. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141, 320\u2013327 (2010).","journal-title":"J. Control. Release"},{"key":"53254_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/bj20031253","volume":"377","author":"J Rejman","year":"2004","unstructured":"Rejman, J., Oberle, V., Zuhorn, I. S. & Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 377, 159\u2013169 (2004).","journal-title":"Biochem. J."},{"key":"53254_CR31","doi-asserted-by":"crossref","unstructured":"Monopoli, M. P., Aberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nano-enabled Med. Appl. 205\u2013229 (2020).","DOI":"10.1201\/9780429399039-7"},{"key":"53254_CR32","doi-asserted-by":"publisher","first-page":"14265","DOI":"10.1073\/pnas.0805135105","volume":"105","author":"M Lundqvist","year":"2008","unstructured":"Lundqvist, M. et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. 105, 14265\u201314270 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"53254_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee, S. DLS and zeta potential\u2014What they are and what they are not?. J. Control. Release 235, 337\u2013351 (2016).","journal-title":"J. Control. Release"},{"key":"53254_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld, J., McKenna, S. A. & Patel, T. R. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys. Rev. 8, 409\u2013427 (2016).","journal-title":"Biophys. Rev."},{"key":"53254_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11051-008-9435-7","volume":"10","author":"CM Hoo","year":"2008","unstructured":"Hoo, C. M., Starostin, N., West, P. & Mecartney, M. L. A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions. J. Nanopart. Res. 10, 89\u201396 (2008).","journal-title":"J. Nanopart. Res."},{"key":"53254_CR36","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1039\/D3MH00717K","volume":"10","author":"SK Filippov","year":"2023","unstructured":"Filippov, S. K. et al. Dynamic light scattering and transmission electron microscopy in drug delivery: A roadmap for correct characterization of nanoparticles and interpretation of results. Mater. Horiz. 10, 5354\u20135370 (2023).","journal-title":"Mater. Horiz."},{"key":"53254_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.micromeso.2022.111919","volume":"337","author":"I Akbarzadeh","year":"2022","unstructured":"Akbarzadeh, I. et al. Gingerol\/letrozole-loaded mesoporous silica nanoparticles for breast cancer therapy: In-silico and in-vitro studies. Microporous Mesoporous Mater. 337, 111919 (2022).","journal-title":"Microporous Mesoporous Mater."},{"key":"53254_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.598722","volume":"8","author":"Y Gao","year":"2020","unstructured":"Gao, Y., Gao, D., Shen, J. & Wang, Q. A review of mesoporous silica nanoparticle delivery systems in chemo-based combination cancer therapies. Front. Chem. 8, 598722. https:\/\/doi.org\/10.3389\/fchem.2020.598722 (2020).","journal-title":"Front. Chem."},{"key":"53254_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/B978-0-12-817909-3.00010-8","volume-title":"Basic Fundamentals of Drug Delivery","author":"N Raval","year":"2019","unstructured":"Raval, N. et al. Basic Fundamentals of Drug Delivery 369\u2013400 (Elsevier, 2019)."},{"key":"53254_CR40","doi-asserted-by":"publisher","first-page":"18462","DOI":"10.1021\/acsami.7b02457","volume":"9","author":"W Cheng","year":"2017","unstructured":"Cheng, W. et al. pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl. Mater. Interfaces 9, 18462\u201318473 (2017).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"53254_CR41","unstructured":"Barkat, A. et al. in Seminars in Cancer Biology. 365\u2013375 (Elsevier)."},{"key":"53254_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1246\/bcsj.20210428","volume":"95","author":"S Tiburcius","year":"2022","unstructured":"Tiburcius, S. et al. Triple surfactant assisted synthesis of novel core-shell mesoporous silica nanoparticles with high surface area for drug delivery for prostate cancer. Bull. Chem. Soc. Jpn. 95, 331\u2013340 (2022).","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"53254_CR43","unstructured":"Lestari, W., Wahyuningsih, S., Gomez-Ruiz, S. & Wibowo, F. in Journal of Physics: Conference Series. 012032 (IOP Publishing)."},{"key":"53254_CR44","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/pharmaceutics15061624","volume":"15","author":"G Figari","year":"2023","unstructured":"Figari, G. et al. Understanding fenofibrate release from bare and modified mesoporous silica nanoparticles. Pharmaceutics 15, 1624 (2023).","journal-title":"Pharmaceutics"},{"key":"53254_CR45","doi-asserted-by":"publisher","first-page":"31031","DOI":"10.1016\/j.ceramint.2021.08.129","volume":"47","author":"Y Hu","year":"2021","unstructured":"Hu, Y., Bai, S., Wu, X., Tan, S. & He, Y. Biodegradability of mesoporous silica nanoparticles. Ceram. Int. 47, 31031\u201331041 (2021).","journal-title":"Ceram. Int."},{"key":"53254_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/powders2010001","volume":"2","author":"A Hutin","year":"2022","unstructured":"Hutin, A., Lima, N., Lopez, F. & Carvalho, M. Stability of silica nanofluids at high salinity and high temperature. Powders 2, 1\u201320 (2022).","journal-title":"Powders"},{"key":"53254_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/adfm.201001495","volume":"21","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv. Funct. Mater. 21, 270\u2013278. https:\/\/doi.org\/10.1002\/adfm.201001495 (2011).","journal-title":"Adv. Funct. Mater."},{"key":"53254_CR48","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S113815","volume":"9","author":"P Khosravian","year":"2016","unstructured":"Khosravian, P. et al. Mesoporous silica nanoparticles functionalized with folic acid\/methionine for active targeted delivery of docetaxel. OncoTargets Ther. 9, 7315. https:\/\/doi.org\/10.2147\/OTT.S113815 (2016).","journal-title":"OncoTargets Ther."},{"key":"53254_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/9783110470734-007","volume":"18","author":"IA Riddell","year":"2018","unstructured":"Riddell, I. A. & Lippard, S. J. Cisplatin and oxaliplatin: our current understanding of their actions. Met. Ions Life Sci. 18, 1\u201342. https:\/\/doi.org\/10.1515\/9783110470734-007 (2018).","journal-title":"Met. Ions Life Sci."},{"key":"53254_CR50","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1021\/nn2033105","volume":"5","author":"Y Gao","year":"2011","unstructured":"Gao, Y. et al. The effect of interlayer adhesion on the mechanical behaviors of macroscopic graphene oxide papers. ACS Nano 5, 2134\u20132141. https:\/\/doi.org\/10.1021\/nn2033105 (2011).","journal-title":"ACS Nano"},{"key":"53254_CR51","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/smll.200901789","volume":"6","author":"JL Vivero-Escoto","year":"2010","unstructured":"Vivero-Escoto, J. L., Slowing, I. I., Trewyn, B. G. & Lin, V. S. Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6, 1952\u20131967. https:\/\/doi.org\/10.1002\/smll.200901789 (2010).","journal-title":"Small"},{"key":"53254_CR52","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/smll.201000538","volume":"6","author":"J Lu","year":"2010","unstructured":"Lu, J., Liong, M., Li, Z., Zink, J. I. & Tamanoi, F. Biocompatibility, biodistribution, and drug\u2010delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6, 1794\u20131805 (2010).","journal-title":"Small"},{"key":"53254_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27021092","volume":"27","author":"M Slavkova","year":"2026","unstructured":"Slavkova, M. et al. Synthesis of folic acid-functionalized hybrid mesoporous silica nanoparticles and in vitro evaluation on MCF-7 breast cancer cells. Int. J. Mol. Sci. 27, 1092 (2026).","journal-title":"Int. J. Mol. Sci."},{"key":"53254_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/med.21379","volume":"36","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Direct activation of Bax protein for cancer therapy. Med. Res. Rev. 36, 313\u2013341. https:\/\/doi.org\/10.1002\/med.21379 (2016).","journal-title":"Med. Res. Rev."},{"key":"53254_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","volume":"1644","author":"V Kirkin","year":"2004","unstructured":"Kirkin, V., Joos, S. & Z\u00f6rnig, M. The role of Bcl-2 family members in tumorigenesis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1644, 229\u2013249. https:\/\/doi.org\/10.1016\/j.bbamcr.2003.08.009 (2004).","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"53254_CR56","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15098","volume":"8","author":"P Li","year":"2017","unstructured":"Li, P. et al. Caspase-9: Structure, mechanisms and clinical application. Oncotarget 8, 23996. https:\/\/doi.org\/10.18632\/oncotarget.15098 (2017).","journal-title":"Oncotarget"},{"key":"53254_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122918","volume":"20","author":"Z-L Kong","year":"2019","unstructured":"Kong, Z.-L., Kuo, H.-P., Johnson, A., Wu, L.-C. & Chang, K. L. B. Curcumin-loaded mesoporous silica nanoparticles markedly enhanced cytotoxicity in hepatocellular carcinoma cells. Int. J. Mol. Sci. 20, 2918 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"53254_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/nano7080230","volume":"7","author":"R Kr\u0119towski","year":"2017","unstructured":"Kr\u0119towski, R. et al. The effects of silica nanoparticles on apoptosis and autophagy of glioblastoma cell lines. Nanomaterials 7, 230. https:\/\/doi.org\/10.3390\/nano7080230 (2017).","journal-title":"Nanomaterials"},{"key":"53254_CR59","first-page":"6075","volume":"10","author":"G Liu","year":"2015","unstructured":"Liu, G. et al. Cytotoxicity of various types of gold-mesoporous silica nanoparticles in human breast cancer cells. Int. J. Nanomedicine 10, 6075 (2015).","journal-title":"Int. J. Nanomedicine"},{"key":"53254_CR60","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ejmech.2014.06.069","volume":"83","author":"L Ma\u2019Mani","year":"2014","unstructured":"Ma\u2019Mani, L. et al. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: Practical strategy for the breast cancer therapy. Eur. J. Med. Chem. 83, 646\u2013654 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"53254_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares, J. et al. Molecular principles of metastasis: A hallmark of cancer revisited. Signal Transduct. Targeted Therapy 5, 28 (2020).","journal-title":"Signal Transduct. Targeted Therapy"},{"key":"53254_CR62","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/jbm.a.37288","volume":"110","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. Dual drug release mechanisms through mesoporous silica nanoparticle\/electrospun nanofiber for enhanced anticancer efficiency of curcumin. J. Biomed. Mater. Res. Part A 110, 316\u2013330 (2022).","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"53254_CR63","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1038\/s41467-018-04865-7","volume":"9","author":"E Infante","year":"2018","unstructured":"Infante, E. et al. LINC complex-Lis1 interplay controls MT1-MMP matrix digest-on-demand response for confined tumor cell migration. Nat. Commun. 9, 2443 (2018).","journal-title":"Nat. Commun."},{"key":"53254_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213710","volume":"156","author":"M Kasravi","year":"2024","unstructured":"Kasravi, M. et al. MMP inhibition as a novel strategy for extracellular matrix preservation during whole liver decellularization. Biomater. Adv. 156, 213710 (2024).","journal-title":"Biomater. Adv."},{"key":"53254_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-5173(97)00404-3","volume":"164","author":"H Takeuchi","year":"1998","unstructured":"Takeuchi, H. et al. Physical stability of size controlled small unilameller liposomes coated with a modified polyvinyl alcohol. Int. J. Pharm. 164, 103\u2013111 (1998).","journal-title":"Int. J. Pharm."},{"key":"53254_CR66","doi-asserted-by":"crossref","unstructured":"Chen, Y.-L. et al. Higenamine combined with [6]-gingerol suppresses doxorubicin-triggered oxidative stress and apoptosis in cardiomyocytes via upregulation of PI3K\/Akt pathway. Evid. Based Complement. Altern. Med. 2013 (2013).","DOI":"10.1155\/2013\/970490"},{"key":"53254_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2009.05.015","volume":"287","author":"JH Joo","year":"2010","unstructured":"Joo, J. H. & Jetten, A. M. J. C. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett. 287, 123\u2013135 (2010).","journal-title":"Cancer Lett."},{"key":"53254_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ars.2007.9.49","volume":"9","author":"SW Ryter","year":"2007","unstructured":"Ryter, S. W. et al. Mechanisms of cell death in oxidative stress. Antioxidants Redox Signal. 9, 49\u201389 (2007).","journal-title":"Antioxidants Redox Signal."},{"key":"53254_CR69","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.biocel.2009.01.002","volume":"41","author":"X-L Li","year":"2009","unstructured":"Li, X.-L. et al. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int. J. Biochem. Cell Biol. 41, 1526\u20131535 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"53254_CR70","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo, B. et al. ROS in cancer therapy: The bright side of the moon. Exp. Mol. Med. 52, 192\u2013203 (2020).","journal-title":"Exp. Mol. Med."},{"key":"53254_CR71","doi-asserted-by":"crossref","unstructured":"Hughes, B., Chatterjee, S., Ghafari, M. & Cisneros, G. A. Effects of a cancer-associated mutation and multiple serine phosphorylation on poly (ADP-ribose) polymerase 2. Biophys. J. (2025).","DOI":"10.1016\/j.bpj.2025.07.025"},{"key":"53254_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.701301","volume":"12","author":"MI Avrutsky","year":"2021","unstructured":"Avrutsky, M. I. & Troy, C. M. Caspase-9: A multimodal therapeutic target with diverse cellular expression in human disease. Front. Pharmacol. 12, 701301 (2021).","journal-title":"Front. Pharmacol."},{"key":"53254_CR73","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/0960327117703687","volume":"37","author":"S Mahdavi","year":"2018","unstructured":"Mahdavi, S., Khodarahmi, P. & Roodbari, N. Effects of cadmium on Bcl-2\/Bax expression ratio in rat cortex brain and hippocampus. J. H. Toxicol. e. 37, 321\u2013328 (2018).","journal-title":"J. H. Toxicol. e."},{"key":"53254_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118688","volume":"1867","author":"A Boice","year":"2020","unstructured":"Boice, A. & Bouchier-Hayes, L. Targeting apoptotic caspases in cancer. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1867, 118688 (2020).","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"53254_CR75","doi-asserted-by":"crossref","unstructured":"Zhou, M. et al. Caspase\u20103 regulates the migration, invasion and metastasis of colon cancer cells. 143, 921\u2013930 (2018).","DOI":"10.1002\/ijc.31374"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53254-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53254-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53254-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:30:16Z","timestamp":1784075416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53254-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53254"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53254-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to the publication of this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22218"}}